Pathology Probes for Breast Cancer Brochure
The Cytocell Pathology Probes for Breast Cancer brochure highlights our range of products suitable for investigating genetic aberrations seen in breast cancer.
Breast cancer is the most commonly diagnosed cancer in women and comprises 25% of all reported cancer cases. Worldwide, there were 1.67 million new cases, with an estimated 522,000 deaths in 20121.
FISH testing on breast cancer samples can give important information about the patient’s disease, and in some cases may help direct patient management decisions2.
1. Ervik M et al., Cancer Today. Lyon, France 2016. http://gco.iarc.fr/today, accessed 22/02/2017
2. Rakha E.A. et al., Journal of Clinical Pathology 2015,68:93–99.